Financial Results
The material used in the financial results and financial results briefing, which describes qualitative information such as business results,management policies, and financial statements. are posted.
Annual Securities Report
This document discloses company details prepared for each fiscal year in accordance with the Financial Instruments and Exchange Act.
Integrated Report
The Company annually provides its management strategy and ESG information along with a corporate message from its executives.
Shareholder newsletters
(Japanese version only) We will send our shareholders a biannual shareholders' newsletter containing the latest information on our business, financial results, topics, etc.
Shareholders' Meeting
The date, time, and the venue of the general meeting of shareholders, and the materials available to them are posted.
Top Message
A message from Takashi Yamaguchi, President and Representative Director, to our shareholders and investors.
Medium-Term Management Plan
Our medium-to-long-term management strategy is outlined.
Business Risks
Matters related to business conditions and accounting conditions that may have a significant impact on investors' decisions.
Disclosure Policy
Our Disclosure policy to provide timely and appropriate information
Basic Principles / Corporate Governance Structure
This page describes our Basic Principles and Corporate Governance Structure
Corporate Governance Basic Policy
We has established this Basic Policy based on a resolution of its Board of Directors in an effort to establish and maintain the best and most effective corporate governance system.
Corporate Governance Report
(Japanese version only) This page describes status of our corporate governance.
Board Members
This page describes our Members of the Board of Directors/Audit & Supervisory Board Members.
Compliance / Risk Management
This page describes our Compliance and Risk Management
Internal Control System
This page describes our internal control system.
Material Issues: G
This page describes our Material Issues.
ESG Chart and ESG Data Book
This page describes ESG data.
Performance Review
Reviews of recent business performance and future outlook of the Company are available here.
Performance Highlights
Graphs and numerical data on Sales, Operating profit, and other key financial figures are available here.
Financial Conditions
Graphs and numerical data on total assets, net assets, and other major financial figures are available here.
Financial Statements
Balance sheets, income statements, and cash flow statements are available here.
Earnings Forecast
Information on our business forecasts is available here.
Point1 About ASKA -Understanding & History–
The history of ASKA Pharmaceutical, from its founding in 1893 to the present, is introduced here with photos.
Point2 About ASKA -Strengths-
ASKA Pharmaceutical's strength comes from its high level of specialization in the three therapeutic areas of internal medicine, obstetrics and gynecology, and urology.
Point3 Highly specialized product lineup
Major products in internal medicine, obstetrics & gynecology, and urology are introduced here.
Point4 Continuously evolving R&D
Aiming to continuously create innovative new drugs with high value, we are working to strengthen our R&D capabilities.
Point5 Stable Shareholder Returns
We regard the return of profits to shareholders as an important management issue and pay stable dividends.
Frequently Asked Questions
Frequently asked questions from shareholders and investors are summarized here.
Stock summary information
Stock information such as fiscal year and shareholder composition are posted.
Shareholder Information
Top 10 Shareholders and Distribution of Shares
Stock Price Information
Stock price and stock chart
Dividends and Dividend Payout Ratio
Dividend policy and dividends are available here.
Articles of Incorporation and Stock Handling Regulations
(Japanese version only) Articles of Incorporation and Stock Handling Regulations
Analyst Coverage
List of analysts covering the Company